San Carlos, CA, United States of America

Jaw-Kang Chang

This inventor holds 14 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Phoenix Pharmaceuticals, Inc., University of California, Leland Stanford Junior University. Active years: 1976-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jaw-Kang Chang. Retrieved from https://idiyas.com/inventor/jaw-kang-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 92.9

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 184(Granted Patents)

Location History:

Mountain View, CA (US) (1976)
Belmont, CA (US) (1985)
San Carlos, CA (US) (1984 - 2020)

Company Filing History:

7 out of 7

Phoenix Pharmaceuticals, Inc.

patents

2 out of 16,025

University of California

patents

1 out of 5,512

Leland Stanford Junior University

patents

4. 1 out of 1

Peninsula Laboratories, Inc.

patent

5. 3 out of 834,513

Other

patents

Years Active: 1976-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12103965 - Diagnostic kit (2024-10-01),

2. 10836812 - Phoenixin peptides (2020-11-17),

3. 9534045 - Phoenixin peptides (2017-01-03),

4. 9018350 - Phoenixin peptides (2015-04-28),

5. 7928186 - Cell permeable bioactive peptide conjugates (2011-04-19),

6. 7462355 - Angiogenesis regulation system (2008-12-09),

7. 6835806 - Cell growth regulation system (2004-12-28),

8. 4721704 - Potent synthetic atrial peptide analogs (1988-01-26),

9. 4684624 - Method of treating cerebral ischemia (1987-08-04),

10. 4613586 - Gastrin releasing peptide-like peptides (1986-09-23),

11. 4562175 - Synthetic peptides (1985-12-31),

12. 4481191 - Method for controlling blood pressure (1984-11-06),

13. 4462941 - Dynorphin amide analogs (1984-07-31),

14. 3953416 - Synthetic decapeptide having the activity of the luteinizing hormone (1976-04-27),

Title: Jaw-Kang Chang: Pioneering Innovator in Technology

Introduction:

Jaw-Kang Chang, a visionary inventor based in San Carlos, CA (US), has made significant contributions to the realm of technology through his relentless pursuit of innovation and passion for solving complex challenges.

Latest Patents:

With an impressive portfolio of 13 patents, Jaw-Kang Chang's latest breakthrough involves Phoenixin peptides. These peptides, along with their analogs and mimetics, are invaluable for producing anti-phoenixin antibodies, diagnostic screenings, modulating cellular concentration of cAMP, treating disorders related to cAMP or Caconcentration in cells, and more.

Career Highlights:

Throughout his career, Jaw-Kang Chang has showcased a remarkable ability to innovate and push boundaries in technology. His work at companies such as Phoenix Pharmaceuticals, Inc. has been instrumental in shaping the landscape of technological advancements.

Collaborations:

Jaw-Kang Chang has collaborated with esteemed professionals in the field, including Nancy M Lee and Rong-Ming Lyu. Together, they have worked on cutting-edge projects that have had a lasting impact on technology and innovation.

Conclusion:

In conclusion, Jaw-Kang Chang's pioneering spirit and dedication to innovation have cemented his reputation as a visionary inventor. His contributions to the field of technology continue to inspire and drive progress in solving complex challenges.

Profile summary based on public USPTO records.